Spyglass Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $97.5M | Sell |
|
|||||
|
2024
Q2 | $90.4M | Buy |
|
|||||
|
2024
Q1 | $92.8M | Buy |
|
|||||
|
2023
Q4 | $68M | Sell |
|
|||||
|
2023
Q3 | $57.6M | Sell |
|
|||||
|
2023
Q2 | $58.7M | Sell |
|
|||||
|
2023
Q1 | $76.6M | Sell |
|
|||||
|
2022
Q4 | $87.3M | Sell |
|
|||||
|
2022
Q3 | $98.1M | Sell |
|
|||||
|
2022
Q2 | $103M | Sell |
|
|||||
|
2022
Q1 | $141M | Sell |
|
|||||
|
2021
Q4 | $176M | Sell |
|
|||||
|
2021
Q3 | $220M | Buy |
|
|||||
|
2021
Q2 | $148M | Buy |
|
|||||
|
2021
Q1 | $125M | Buy |
|
|||||
|
2020
Q4 | $117M | Buy |
|
|||||
|
2020
Q3 | $84.4M | Buy |
|
|||||
|
2020
Q2 | $66.9M | Buy |
|
|||||
|
2020
Q1 | $39.6M | Buy |
|
|||||
|
2019
Q4 | $34.9M | Buy |
|
|||||
|
2019
Q3 | $12.9M | Buy |
|
|||||
|
2019
Q2 | $12.8M | Buy |
|
|||||
|
2019
Q1 | $10.6M | Buy |
|
|||||
|
2018
Q4 | $2.7M | Buy |
|